Establishment and characterization of a new human mesothelioma cell line (T‐85) from malignant peritoneal mesothelioma with remarkable thrombocytosis
Establishment and characterization of a new human mesothelioma cell line (T‐85) from malignant peritoneal mesothelioma with remarkable thrombocytosis
复制标题
具有显着血小板增多症的恶性腹膜间皮瘤的新人间皮瘤细胞系(T-85)的建立和表征
DOI:
--
复制
发表时间:
1995
期刊:
影响因子:
--
通讯作者:
R. Machinami
中科院分区:
文献类型:
--
作者:
T. Tange;Y. Hasegawa;T. Oka;S. Sunaga;M. Higashihara;K. Matsuo;H. Miyazaki;A. Shimosaka;A. Okano;K. Todokoro;T. Ishikawa;R. Machinami
A mesothelioma cell line, termed T‐85, was established from a patient with malignant peritoneal mesothelioma and remarkable thrombocytosis (1.4 × 106/mm3). Electron microscopically, two types of mesothelioma cells have been characterized; the major type of cells with dense‐cored granules in the cytoplasm and the minor one with evenly dense granules. Immunologically, the cells showed staining for inter‐leukin‐6 (IL‐6), cytokeratin, collagen type IV, vimentin, laminin, fibronectin and Factor VIII‐related antigen. Quanti‐tation by ELISA revealed a high concentration of IL‐6 in T‐85 cell culture supernatants. RT‐polymerase chain reaction of T‐85 cells showed two positive bands of cDNA at 628 and 251 base pairs indicating the constitutive expression of IL‐6 and IL‐6 receptor mRNA. Moreover, prominent pro‐platelet process formation activity in T‐85 cell culture supernatants indicated the presence of a thrombopoietic activity due mainly to IL‐6 but not the c‐MpI ligand or erythropoietin. However, the fact that 15% of PPF activity remained in the supernatants treated with anti‐IL‐6 antibody indicated the presence of another thrombopoietic substance. T‐85 is so far the first mesothelioma cell line derived from a case with remarkable thrombocytosis.
影响因子:
20.3
作者:
G. Demetri;Beatrice W. Zenzie;J. Rheinwald;J. Griffin
通讯作者:
G. Demetri;Beatrice W. Zenzie;J. Rheinwald;J. Griffin
影响因子:
11.2
作者:
Reale,FR;Griffin,TW;Compton,JM;Graham,S;Townes,PL;Bogden,A
通讯作者:
Bogden,A